Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,437 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
An intensive chemotherapy of adult T-cell leukemia/lymphoma: CHOP followed by etoposide, vindesine, ranimustine, and mitoxantrone with granulocyte colony-stimulating factor support.
Taguchi H, Kinoshita KI, Takatsuki K, Tomonaga M, Araki K, Arima N, Ikeda S, Uozumi K, Kohno H, Kawano F, Kikuchi H, Takahashi H, Tamura K, Chiyoda S, Tsuda H, Nishimura H, Hosokawa T, Matsuzaki H, Momita S, Yamada O, Miyoshi I. Taguchi H, et al. Among authors: ikeda s. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Jun 1;12(2):182-6. doi: 10.1097/00042560-199606010-00012. J Acquir Immune Defic Syndr Hum Retrovirol. 1996. PMID: 8680890 Clinical Trial.
A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303.
Yamada Y, Tomonaga M, Fukuda H, Hanada S, Utsunomiya A, Tara M, Sano M, Ikeda S, Takatsuki K, Kozuru M, Araki K, Kawano F, Niimi M, Tobinai K, Hotta T, Shimoyama M. Yamada Y, et al. Among authors: ikeda s. Br J Haematol. 2001 May;113(2):375-82. doi: 10.1046/j.1365-2141.2001.02737.x. Br J Haematol. 2001. PMID: 11380402 Free article. Clinical Trial.
DNA aneuploidy of adult T-cell leukemia cells.
Kamihira S, Atogami S, Sohda H, Momita S, Toryia K, Ikeda S, Yamada Y, Tomonaga M. Kamihira S, et al. Among authors: ikeda s. Leuk Res. 1994 Feb;18(2):79-84. doi: 10.1016/0145-2126(94)90122-8. Leuk Res. 1994. PMID: 8107491
Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low- and low-intermediate risk, aggressive non-Hodgkin's lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG9508.
Kagami Y, Itoh K, Tobinai K, Fukuda H, Mukai K, Chou T, Mikuni C, Kinoshita T, Fukushima N, Kiyama Y, Suzuki T, Sasaki T, Watanabe Y, Tsukasaki K, Hotta T, Shimoyama M, Ogura M; Lymphoma Study Group of the Japan Clinical Oncology Group. Kagami Y, et al. Int J Hematol. 2012 Jul;96(1):74-83. doi: 10.1007/s12185-012-1101-2. Epub 2012 Jun 3. Int J Hematol. 2012. PMID: 22661011 Clinical Trial.
Jejunal perforation in a patient with adult T-cell leukemia.
Isomoto H, Ohnita K, Haraguchi M, Mizuta Y, Momita S, Ikeda S, Omagari K, Murase K, Nakayama T, Maeda T, Murata I, Kohno S. Isomoto H, et al. Among authors: ikeda s. Leuk Lymphoma. 2001 Nov-Dec;42(6):1423-7. doi: 10.3109/10428190109097774. Leuk Lymphoma. 2001. PMID: 11911430
4,437 results